ERBB2 and breast carcinoma: For example, in 2020, Freitas et al., used CdSe/ZnS QDs to develop electrochemical immunosensors that could recognize the extracellular domain of the human epidermal growth factor receptor 2 (HER2-ECD), a biomarker of breast cancer cells.